ConductScience.org, home

Paper35366608

Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis.

Karpouzas GA and 4 others. J Autoimmun, 2022. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis. Papers, record 35366608. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35366608

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis.
PubMed
Journal
J Autoimmun
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
1.71
iCite
Revised in PubMed
2022-07-15
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Karpouzas GAGeorge A
2Ormseth SRSarah R
3Ronda NNicoletta
4Hernandez EElizabeth
5Budoff MJMatthew J

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, RheumatoidMajor topic
AtherosclerosisMajor topic
C-Reactive Protein
Cholesterol, LDL
Humans
Interleukin-6
Lipoprotein(a)
Lipoproteins, LDL
Proprotein Convertase 9
Tumor Necrosis Factor-alpha

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
42582123Lipid parameters and disease activity in rheumatoid arthritis: a cross-sectional analysis of the Kuwait registry for rheumatic diseases (KRRD).Front Med (Lausanne)2026https://conductscience.org/library/papers/42582123PubMed
42548760Immunological heterogeneity in rheumatoid arthritis: challenges in early-stage stratification, non-response to targeted therapy, and the restoration of immune tolerance.Front Immunol2026https://conductscience.org/library/papers/42548760PubMed
42183228RORα: a critical nexus in the crosstalk between cholesterol metabolism and macrophage polarization.Front Immunol2026https://conductscience.org/library/papers/42183228PubMed
42099596Atherosclerosis features in rheumatic diseases - focus on peripheral artery disease.Front Immunol2026https://conductscience.org/library/papers/42099596PubMed
42051524Lipid metabolism at the intersection of rheumatoid arthritis and atherosclerosis.Front Immunol2026https://conductscience.org/library/papers/42051524PubMed
41360604Sex and reproductive stage modify the effect of endogenous oestrogens on coronary atherosclerosis in rheumatoid arthritis.RMD Open2025https://conductscience.org/library/papers/41360604PubMed
40943434Post-Translational Modifications of Lipoproteins: Emerging Players Linking Inflammation and Cardiovascular Disease in Rheumatoid Arthritis-A Narrative Review.Int J Mol Sci2025https://conductscience.org/library/papers/40943434PubMed
40176397Metabolic Consequences of Rheumatoid Arthritis.Arthritis Care Res (Hoboken)2025https://conductscience.org/library/papers/40176397PubMed
39831939Cardiovascular Risk Factor and Atherosclerosis in Rheumatoid Arthritis (RA).Curr Cardiol Rep2025https://conductscience.org/library/papers/39831939PubMed
39719397Changes in serum cholesterol loading capacity are linked to coronary atherosclerosis progression in rheumatoid arthritis.RMD Open2024https://conductscience.org/library/papers/39719397PubMed
39456762The Composition of the HDL Particle and Its Capacity to Remove Cellular Cholesterol Are Associated with a Reduced Risk of Developing Active Inflammatory Rheumatoid Arthritis.Int J Mol Sci2024https://conductscience.org/library/papers/39456762PubMed
36411486Prevalence and influence of hypouricemia on cardiovascular diseases in patients with rheumatoid arthritis.Eur J Med Res2022https://conductscience.org/library/papers/36411486PubMed
35955522Relationship between Brain Metabolic Disorders and Cognitive Impairment: LDL Receptor Defect.Int J Mol Sci2022https://conductscience.org/library/papers/35955522PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
PCSK9255738PubTator's text mininghttps://conductscience.org/library/genes/255738NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35366608

GET https://conductscience.org/api/papers/v1/35366608/authors